Singapore markets open in 6 hours 34 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
310.70-6.90 (-2.17%)
As of 01:26PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close317.60
Bid310.37 x 800
Ask310.74 x 900
Day's range310.57 - 317.28
52-week range203.13 - 323.61
Avg. volume1,493,503
Market cap79.754B
Beta (5Y monthly)0.43
PE ratio (TTM)24.37
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    3 Stocks to Buy Before 2023 That Can Set You Up for Life

    Given all the market uncertainty this year and the downward trend of the major indices, it's no surprise that some investors are hesitant to buy right now. Knowing the right time to pull the trigger on a stock purchase (or a sale) is often one of the hardest parts of being an investor. Three such buy-now opportunities are Vertex Pharmaceuticals (NASDAQ: VRTX), Mattel (NASDAQ: MAT), and Nvidia (NASDAQ: NVDA).

  • Motley Fool

    Is It Too Late to Buy Vertex Pharmaceuticals Stock?

    Take Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that has delivered market-beating returns over the past decade. The drugmaker is still at it even amid the market downturn and currently sits near its 52-week high. Vertex has certainly been impressive, but are the company's best days already in the rearview mirror?

  • Zacks

    GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe

    GSK's new drug application (NDA) for momelotinib is under standard FDA review, with a decision expected on Jun 16, 2023.